Showing results (1-10 of 97) with videos related to
Sort By:
Pageof 10
Thrombosis Journal|November 2, 2013
Main considerable factors for correct laboratory test interpretation under DOA treatmentHelen Mani, Edelgard Lindhoff-LastDrug Design, Development and Therapy|June 28, 2014
New oral anticoagulants in patients with nonvalvular atrial fibrillation: a review of pharmacokinetics, safety, efficacy, quality of life, and cost effectivenessHelen Mani, Edelgard Lindhoff-LastClinical Chemistry and Laboratory Medicine|December 24, 2010
Platelet function testing in hirudin and BAPA anticoagulated bloodHelen Mani, Mirna Hellis, Edelgard Lindhoff-LastJournal of Thrombosis and Thrombolysis|March 21, 2013
Measuring the anticoagulant effects of target specific oral anticoagulants-reasons, methods and current limitationsHelen Mani, Alexander Kasper, Edelgard Lindhoff-LastThrombosis and Haemostasis|November 10, 2012
Ex vivo effects of low-dose rivaroxaban on specific coagulation assays and coagulation factor activities in patients under real life conditionsHelen Mani, Christian Hesse, Gertrud Stratmann, et al.Thrombosis and Haemostasis|June 10, 2011
Rivaroxaban differentially influences ex vivo global coagulation assays based on the administration timeHelen Mani, Christian Hesse, Gertrud Stratmann, et al.Annals of Hematology|February 28, 2009
Variability of non-response to aspirin in patients with peripheral arterial occlusive disease during long-term follow-upBirgit Linnemann, Stephanie Prochnow, Helen Mani, et al.Hamostaseologie|March 28, 2018
Direct oral anticoagulants (DOAC) - Management of emergency situationsEdelgard Lindhoff-LastPlatelets|August 25, 2006
Response to aspirin and clopidogrel monitored with different platelet function methodsHelen Mani, Birgit Linnemann, Beate Luxembourg, et al.Annals of Hematology|January 6, 2010
Assessment of clopidogrel non-response by the PFA-100 system using the new test cartridge INNOVANCE PFA P2YBirgit Linnemann, Jan Schwonberg, Andreas R Rechner, et al.Pageof 10